Table 1. The results of the steroid profile MS measurement for patients with androgen deficiency(AD) and control group.
|
Parameter |
Control group |
Group with AD |
p-value |
| Cortisol, nmol/l |
215.1(196.2, 300.6) |
344.3(284.5, 410) |
0.003878 |
| 11-Deoxicortisole, nmol/l |
0.63(0.57, 0.82) |
0.63 (0.40, 0.79) |
0.6142 |
| Corticosterone, nmol/l |
4.27(3.21, 7.80) |
8.90(5.71, 14.86) |
0.03233 |
| DHEAS, µmol/l |
5.64(4.21, 8.0) |
3.83(2.78, 5.44) |
0.03809 |
| Testosterone, nmol/l |
0.93(0.77, 1.04) |
0.67(0.56, 0.96) |
0.03931 |
| Androsten-3,17-dione, nmol/l |
4.52(3.31, 4.99) |
3.18(2.48, 4.27) |
0.05872 |
| 17-a-OH-progesterone, nmol/l |
1.24(0.69, 1.87) |
0.93(0.65,1.84) |
0.5225 |
| Dihydrotestosterone, pg/ml |
122.4(121.9, 224.4) |
94.3(76.6, 190.8) |
0.246 |
| Progesterone, nmol/l |
0.74 (0.67, 7.55) |
1.13 (0.82, 4.05) |
0.2805 |